Literature DB >> 19707133

Critical care of the burn patient: the first 48 hours.

Barbara A Latenser1.   

Abstract

OBJECTIVE: The goal of this concise review is to provide an overview of some of the most important resuscitation and monitoring issues and approaches that are unique to burn patients compared with the general intensive care unit population. STUDY SELECTION: Consensus conference findings, clinical trials, and expert medical opinion regarding care of the critically burned patient were gathered and reviewed. Studies focusing on burn shock, resuscitation goals, monitoring tools, and current recommendations for initial burn care were examined.
CONCLUSIONS: The critically burned patient differs from other critically ill patients in many ways, the most important being the necessity of a team approach to patient care. The burn patient is best cared for in a dedicated burn center where resuscitation and monitoring concentrate on the pathophysiology of burns, inhalation injury, and edema formation. Early operative intervention and wound closure, metabolic interventions, early enteral nutrition, and intensive glucose control have led to continued improvements in outcome. Prevention of complications such as hypothermia and compartment syndromes is part of burn critical care. The myriad areas where standards and guidelines are currently determined only by expert opinion will become driven by level 1 data only by continued research into the critical care of the burn patient.

Entities:  

Mesh:

Year:  2009        PMID: 19707133     DOI: 10.1097/CCM.0b013e3181b3a08f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  26 in total

Review 1.  [Antimicrobial treatment in burn injury patients].

Authors:  T Trupkovic; J Gille; H Fischer; S Kleinschmidt
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 2.  Surgical intensive care unit--the trauma surgery perspective.

Authors:  Christian Kleber; Klaus Dieter Schaser; Norbert P Haas
Journal:  Langenbecks Arch Surg       Date:  2011-03-03       Impact factor: 3.445

3.  Burn-injury affects gut-associated lymphoid tissues derived CD4+ T cells.

Authors:  Nadeem Fazal; Alla Shelip; Alhusain J Alzahrani
Journal:  Results Immunol       Date:  2013-09-25

Review 4.  Implications of augmented renal clearance in critically ill patients.

Authors:  Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

5.  Effects of glutamine treatment on myocardial damage and cardiac function in rats after severe burn injury.

Authors:  Hong Yan; Yong Zhang; Shang-jun Lv; Lin Wang; Guang-ping Liang; Qian-xue Wan; Xi Peng
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

6.  Burn and smoke injury activates poly(ADP-ribose)polymerase in circulating leukocytes.

Authors:  Eva Bartha; Sven Asmussen; Gabor Olah; Sebastian W Rehberg; Yusuke Yamamoto; Daniel L Traber; Csaba Szabo
Journal:  Shock       Date:  2011-08       Impact factor: 3.454

7.  Burns: learning from the past in order to be fit for the future.

Authors:  Lars-Peter Kamolz
Journal:  Crit Care       Date:  2010-02-10       Impact factor: 9.097

8.  The management of pain associated with wound care in severe burn patients in Spain.

Authors:  Antonio Mendoza; Fernando L Santoyo; Alberto Agulló; José L Fenández-Cañamaque; Carmen Vivó
Journal:  Int J Burns Trauma       Date:  2016-01-10

9.  Major burn injury is not associated with acute traumatic coagulopathy.

Authors:  Rommel P Lu; Ai Ni; Feng-Chang Lin; Shiara M Ortiz-Pujols; Sasha D Adams; Dougald M Monroe; Herbert C Whinna; Bruce A Cairns; Nigel S Key
Journal:  J Trauma Acute Care Surg       Date:  2013-06       Impact factor: 3.313

10.  Effects of glycyl-glutamine dipeptide supplementation on myocardial damage and cardiac function in rats after severe burn injury.

Authors:  Yong Zhang; Hong Yan; Shang-Gun Lv; Lin Wang; Guang-Ping Liang; Qian-Xue Wan; Xi Peng
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.